Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sushma, Hamal"'
Publikováno v:
Journal of pediatric hematology/oncology. 43(7)
Chediak-Higashi syndrome is a rare immunodeficiency disorder for which hematopoietic stem cell transplant (HSCT) is the only curative treatment option. HSCT only corrects the hematological and immunologic manifestations of the disease but neurologica
Autor:
Stephen L Walker, Peter G Nicholls, Sushmita Dhakal, Rachel A Hawksworth, Murdo Macdonald, Kishori Mahat, Shudan Ruchal, Sushma Hamal, Deanna A Hagge, Kapil D Neupane, Diana N J Lockwood
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 5, Iss 4, p e1041 (2011)
BACKGROUND: Leprosy Type 1 reactions are a major cause of nerve damage and the preventable disability that results. Type 1 reactions are treated with oral corticosteroids and there are few data to support the optimal dose and duration of treatment. T
Externí odkaz:
https://doaj.org/article/7c3c9703b30243a7aa72914fefc0e935
Publikováno v:
Pediatric Hematology Oncology Journal. 4:S45-S46
Publikováno v:
Pediatric Hematology Oncology Journal. 4:S46-S47
Publikováno v:
Pediatric Hematology Oncology Journal. 4:S45
Autor:
Murdo Macdonald, Deanna A. Hagge, Shudan Ruchal, Kishori Mahat, Chaman Ranjit, Sushma Hamal, Kapil D. Neupane, Diana N. J. Lockwood, S Dhakal, Sara E. Atkinson, RA Hawksworth, Chrissy h. Roberts, Bishwa Raj Sapkota, Saraswoti Khadge, Stephen L. Walker
Publikováno v:
British Journal of Dermatology. 167:29-35
BACKGROUND: Leprosy is complicated by immunological reactions which can occur before, during and after successful completion of multidrug therapy. Genetic studies have suggested that polymorphisms in toll-like receptors (TLRs) may affect the suscepti
Autor:
Diana N. J. Lockwood, Kapid Dev Neupane, Shudan Ruchal, Kishori Mahat, S Dhakal, RA Hawksworth, Stephen L. Walker, Deanna A. Hagge, Peter G. Nicholls, Murdo Macdonald, Sushma Hamal
Publikováno v:
Leprosy Review. 83:154-163
Objectives To determine whether the measured change in score of a validated clinical severity scale reflected physician assessed improvement in individuals who had received corticosteroid therapy for leprosy associated nerve damage. Design Patients w
Autor:
Stephen L, Walker, Peter G, Nicholls, Sushmita, Dhakal, Rachel A, Hawksworth, Murdo, Macdonald, Kishori, Mahat, Shudan, Ruchal, Sushma, Hamal, Deanna A, Hagge, Kapid Dev, Neupane, Diana N J, Lockwood
Publikováno v:
Leprosy review. 83(2)
To determine whether the measured change in score of a validated clinical severity scale reflected physician assessed improvement in individuals who had received corticosteroid therapy for leprosy associated nerve damage.Patients with nerve function
Autor:
Diana N. J. Lockwood, Deanna A. Hagge, Kishori Mahat, RA Hawksworth, Peter G. Nicholls, Shudan Ruchal, Stephen L. Walker, S Dhakal, Sushma Hamal, Murdo Macdonald, Kapil D. Neupane
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 5, Iss 4, p e1041 (2011)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Background Leprosy Type 1 reactions are a major cause of nerve damage and the preventable disability that results. Type 1 reactions are treated with oral corticosteroids and there are few data to support the optimal dose and duration of treatment. Ty